Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75,462,362
-
Total 13F shares
-
16,995,470
-
Share change
-
+16,970,470
-
Total reported value
-
$223,661,000
-
Price per share
-
$13.16
-
Number of holders
-
31
-
Value change
-
+$223,332,002
-
Number of buys
-
30
Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q4 2019
As of 31 Dec 2019,
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,995,470 shares.
The largest 10 holders included
NEA Management Company, LLC, Novo Holdings A/S, Sofinnova Investments, Inc., Blackstone Group Inc, ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., Tekla Capital Management LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.